切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2023, Vol. 10 ›› Issue (01) : 57 -61. doi: 10.3877/cma.j.issn.2095-7157.2023.01.015

综述

胃食管反流病治疗的研究进展
王翊钊1, 刘阳1, 叶淑君1, 马连君1,()   
  1. 1. 130033 长春,吉林大学中日联谊医院胃肠内科(内镜中心)
  • 收稿日期:2022-12-09 出版日期:2023-02-15
  • 通信作者: 马连君
  • 基金资助:
    吉林省自然科学基金学科布局项目(20210101248JC)

Research progress of treatment of gastroesophageal reflux disease

Yizhao Wang1, Yang Liu1, Shujun Ye1, Lianjun Ma1,()   

  1. 1. Department of Gastroenterology (Endoscopy Center), China-Japan Union Hospital of Jilin University, Changchun 130033, China
  • Received:2022-12-09 Published:2023-02-15
  • Corresponding author: Lianjun Ma
引用本文:

王翊钊, 刘阳, 叶淑君, 马连君. 胃食管反流病治疗的研究进展[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 57-61.

Yizhao Wang, Yang Liu, Shujun Ye, Lianjun Ma. Research progress of treatment of gastroesophageal reflux disease[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(01): 57-61.

近年来,胃食管反流病(GERD)的患病率呈上升趋势,其病情往往迁延反复,严重影响患者的生活质量。目前,GERD的诊断标准较为明确,治疗方法不断更新,本文将对国内外GERD治疗方法的相关文献进行归纳总结,围绕GERD治疗的研究现状进行阐述。

In recent years, the prevalence of gastroesophageal reflux disease (GERD) has been on the rise, and the illness is often prolonged and difficult to cure, which seriously affects the quality of life of patients. At present, the diagnostic criteria for GERD are relatively clear, while the treatment methods are constantly updated. In this paper, the domestic and foreign literature based on the treatment of gastroesophageal reflux disease were summarized, and the research progress on the treatment of gastroesophageal reflux disease was elaborated.

[1]
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
[2]
陈晨,许军英. 胃食管反流病的研究进展[J]. 临床消化病杂志2014, 26(6): 321-323.
[3]
中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志2020, 40(10): 649-663.
[4]
Kaltenbach T, Crockett S, Gerson LB. Are Lifestyle Measures Effective in Patients With Gastroesophageal Reflux Disease: An Evidence-Based Approach[J]. Arch Intern Med, 2006, 166(9): 965-971.
[5]
Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle Intervention in Gastroesophageal Reflux Disease[J]. Clin Gastroenterol H, 2016, 14(2): 175-182.e3.
[6]
Ness-Jensen E, Lindam A, Lagergren J, et al. Weight Loss and Reduction in Gastroesophageal Reflux. A Prospective Population-Based Cohort Study: The HUNT Study[J]. Am J Gastroenterol, 2013, 108(3): 376-382.
[7]
Yuan LZ, Yi P, Wang GS, et al. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China[J]. Ther Adv Gastroenter, 2019, 12: 175628481987778.
[8]
Xiao Y, Zhang S, Dai N, et al. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis[J]. Gut, 2020, 69(2): 224-230.
[9]
许国铭,方裕强,程能能,等. 质子泵抑制剂(奥美拉唑)试验在胃食管反流病中的诊断价值[J]. 中华消化杂志2002, 22(1): 3-6.
[10]
Graham DY, Tansel A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency[J]. Clin Gastroenterol H, 2018, 16(6): 800-808.e7.
[11]
Khan Z, Alastal Y, Khan MA, et al. On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis[J]. Gastroent Res Pract, 2018, 2018: 1-10.
[12]
Ashida K, Iwakiri K, Hiramatsu N, et al. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole[J]. World J Gastroentero, 2018, 24(14): 1550-1561.
[13]
谭佳成,叶必星,林琳. 胃食管反流病患者长期使用质子泵抑制剂与胃黏膜病变的关系[J]. 中华全科医师杂志2014, 13(2): 124-126.
[14]
Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis[J]. World J Gastroentero, 2017, 23(35): 6500-6515.
[15]
Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis[J]. Aliment Pharm Ther, 2016, 43(2): 240-251.
[16]
陈烨奇,王知非,黄东胜. 海藻酸盐治疗胃食管反流病的研究进展[J]. 浙江临床医学2020, 22(4): 481-483.
[17]
宋顺喆,宫爱霞,郭世斌,等. 内镜技术治疗胃食管反流病的研究进展[J]. 大连医科大学学报2019, 41(5): 448-453.
[18]
Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: A single-center prospective study[J]. J Digest Dis, 2019, 20(5): 229-234.
[19]
Arts J, Bisschops R, Blondeau K, et al. A Double-Blind Sham-Controlled Study of the Effect of Radiofrequency Energy on Symptoms and Distensibility of the Gastro-Esophageal Junction in GERD[J]. Am J Gastroenterol, 2012, 107(2): 222-230.
[20]
DiBaise JK, Brand RE, Quigley EMM. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: Efficacy and potential mechanism of action[J]. Am J Gastroenterology, 2002, 97(4): 833-842.
[21]
Kalapala R, Shah H, Nabi Z, et al. Treatment of gastroesophageal reflux disease using radiofrequency ablation (Stretta procedure): An interim analysis of a randomized trial[J]. Indian J Gastroenter, 2017, 36(5): 337-342.
[22]
Reymunde A, Santiago N. Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up[J]. Gastrointest Endosc, 2007, 65(3): 361-366.
[23]
Lipka S, Kumar A, Richter JE. No Evidence for Efficacy of Radiofrequency Ablation for Treatment of Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis[J]. Clin Gastroenterol H, 2015, 13(6): 1058-1067.e1.
[24]
Chang KJ, Bell R. Transoral Incisionless Fundoplication[J]. Gastrointest Endosc Clin N Am, 2020, 30(2): 267-289.
[25]
Testoni PA, Corsetti M, Di Pietro S, et al. Effect of Transoral Incisionless Fundoplication on Symptoms, PPI Use, and pH-Impedance Refluxes of GERD Patients[J]. World J Surg, 2010, 34(4): 750-757.
[26]
Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study.[J]. Ann Gastroenterol, 2014, 27(4): 346-351.
[27]
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti‐reflux mucosectomy: Experience of 109 cases[J]. Digest Endosc, 2021, 33(3): 347-354.
[28]
Garg R, Mohammed A, Singh A, et al. Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Endosc Int Open, 2022, 10(6): E854-E864.
[29]
Inoue H, Tanabe M, de Santiago ER, et al. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study[J]. Endosc Int Open, 2020, 8(2): E133-E138.
[30]
de SantiagoE ER, Sanchez-Vegazo CT, Peñas B, et al. Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Endosc Int Open, 2021, 9(11): E1740-E1751.
[31]
令狐恩强,王宇菲,王潇潇. 内镜下贲门缩窄术治疗胃食管反流病的报道一例[J/CD]. 中华腔镜外科杂志(电子版), 2013, 6(6): 468-469.
[32]
Liu S, Chai N, Zhai Y, et al. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study[J]. Surg Endosc, 2020, 34(10): 4516-4524.
[33]
曹会霞,熊英,韩静,等. 经口内镜下贲门缩窄术和双倍剂量艾司奥美拉唑治疗难治性胃食管反流病的临床疗效对比[J/CD]. 中华胃肠内镜电子杂志2021, 8(4): 171-175.
[34]
胡海清,柴宁莉,令狐恩强,等. 经口内镜下贲门缩窄术治疗胃食管反流病的临床研究[J/CD]. 中华胃肠内镜电子杂志2016, 3(2): 65-67.
[35]
李治仝,季锋,韩新巍,等. 经口内镜下贲门缩窄术治疗胃食管反流病食管外症状的效果观察[J]. 中华消化杂志2019, 39(6): 405-406.
[36]
Liebermann-Meffert D. Rudolf Nissen (1896-1981)-Perspective[J]. J Gastrointest Surg, 2010, 14(S1): 58-61.
[37]
Dallemagne B, Weerts JM, Jehaes C, et al. Laparoscopic Nissen fundoplication: preliminary report.[J]. Surg Laparosc Endosc, 1991, 1(3): 138-143.
[38]
Gutschow CA, Hölscher AH. Surgical treatment of gastroesophageal reflux disease[J]. Langenbecks Arch Surg, 2013, 398(5): 661-667.
[39]
Demeester TR, Bonavina L, Albertucci M. Nissen Fundoplication for Gastroesophageal Reflux Disease: Evaluation of Primary Repair in 100 Consecutive Patients[J]. Ann Surg, 1986, 204(1): 9-20.
[40]
Skinner DB, Belsey RH. Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients[J]. J Thorac Cardiovasc Surg, 1967, 53(1): 33-54.
[41]
Fenton KN, Miller JI, Lee RB, et al. Belsey Mark IV Antireflux Procedure for Complicated Gastroesophageal Reflux Disease[J]. Ann Thorac Surg, 1997, 64(3): 790-794.
[42]
Peters MJ, Mukhtar A, Yunus RM, et al. Meta-Analysis of Randomized Clinical Trials Comparing Open and Laparoscopic Anti-Reflux Surgery[J]. Am J Gastroenterol, 2009, 104(6): 1548-1561.
[43]
Schietroma M, De Vita F, Carlei F, et al. Laparoscopic Floppy Nissen Fundoplication: 11-Year Follow-up[J]. Surg Laparosc Endosc Percutan Tech, 2013, 23(3): 281-285.
[44]
Dor J, Humbert P, Paoli JM, et al. Treatment of reflux by the so-called modified Heller-Nissen technic[J]. Presse Med (1893), 1967, 75(50): 2563-2565.
[45]
Wenck C, Zornig C. Laparoscopic Toupet fundoplication[J]. Langenbecks Arch Surg, 2010, 395(4): 459-461.
[46]
杜兴,高颖,董庆申,等. 腹腔镜Dor胃底折叠联合His角重建术治疗胃食管反流病的短期疗效观察[J]. 中国医刊2022, 57(3): 268-272.
[47]
郑力铭,蔡则灵,王盛,等. 胃食管反流病的外科治疗现状和进展[J]. 腹部外科2017, 30(4): 319-322,326.
[48]
McKinley SK, Dirks RC, Walsh D, et al. Surgical treatment of GERD: systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(8): 4095-4123.
[49]
Broeders JA, Roks DJ, Ahmed Ali U, et al. Laparoscopic Anterior Versus Posterior Fundoplication for Gastroesophageal Reflux Disease: Systematic Review and Meta-Analysis of Randomized Clinical Trials[J]. Ann Surg, 2011, 254(1): 39-47.
[50]
康珀铭,陶绍霖,谭群友,等. 达芬奇机器人Nissen胃底折叠术治疗难治性胃食管反流病的近期效果[J]. 中国胸心血管外科临床杂志2020, 27(3): 274-278.
[51]
Nakadi IE, Mélot C, Closset J, et al. Evaluation of da Vinci Nissen Fundoplication Clinical Results and Cost Minimization[J]. World J Surg, 2006, 30(6): 1050-1054.
[52]
荀杨芹,刘荣,姚亮,等. 达芬奇机器人辅助与腹腔镜Nissen胃底折叠术治疗成人胃食管反流病的Meta分析[J/CD]. 中华腔镜外科杂志(电子版), 2018, 11(5): 261-267.
[53]
Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic Sphincter Augmentation Device Eliminates Reflux Symptoms and Normalizes Esophageal Acid Exposure: One- and 2-Year Results of a Feasibility Trial[J]. Ann Surg, 2010, 252(5): 857-862.
[54]
Skubleny D, Switzer NJ, Dang J, et al. LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Surg Endosc, 2017, 31(8): 3078-3084.
[1] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[2] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[5] 杨雪, 张伟, 尚培中, 宋创业, 尚丹丹, 张蔚. 胆囊十二指肠瘘结石经瘘口排出后自愈一例报道[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 707-708.
[6] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[7] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[8] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[9] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[10] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[11] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要